Close Menu

NEW YORK – Pressure Biosciences (PBI) said Tuesday that it has entered into a global comarketing agreement with Danaher company Leica Microsystems for a mass spectrometry sample preparation platform.

The platform combines Leica's laser microdissection (LMD) technology, which allows for precise cutting of small biopsy samples, and South Easton, Massachusetts-based PBI's pressure cycling technology (PCT), which aids extraction and digestion of proteins from samples prior to mass spec analysis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A 50-year-old cold case was cracked using genetic genealogy, the New York Times reports.

NPR reports that some insect pests are now becoming resistant to Bt crops.

Science reports the US Food and Drug Administration did not consult an outside panel in its approval of remdesivir as a COVID-19 treatment.

In Nature this week: a framework for future human genomic research, PORE-cupine approach to study RNA structure using nanopore sequencing, and more.

Nov
17
Sponsored by
ACD

Circular RNAs (circRNAs) have recently gained substantial attention in the cancer research field where most, including the putative oncogene ciRS-7 (CDR1as), have been proposed to function as competitive endogenous RNAs (ceRNAs) by “sponging” specific microRNAs.